Electrosprayed PVP/Shellac Composite Medicated Microparticles for Providing Biphasic Drug Release Profile

Abstract:

The present study reports that a sustained release profile could be transferred into a biphasic drug release profile when a hydrophilic polymer was encapsulated into the medicated microparticles. The multiple component composite microparticles were fabricated using a single fluid electrospraying process to treat a co-dissolving solution consisting of a polymer matrix (shellac), an active ingredient (FA), and an additional hydrophilic polymer (poly vinyl pyrrolidone, PVP). FESEM results showed that the microparticles M1 consisting of shellac and FA had an average diameter of 1.27 ± 0.38 μm, whereas the microparticles M2 consisting of shellac, FA and PVP had an average diameter of 1.51 ± 0.34 μm. Both the two types of microparticles were essentially amorphous composites due to the favourable secondary interactions between the components, as demonstrated by ATR-FTIR tests. In vitro dissolution tests demonstrated that the addition of PVP in the microparticles M2 made them give a typical biphasic drug release profile, whereas the double-component microparticles provided a sustained release profile. This study shows a simple way for developing advanced drug delivery systems through tailoring the components of polymer excipients using electrospraying.

• Periodical: Applied Mechanics and Materials (Volumes 633-634)
• Pages: 562-566
• DOI: https://doi.org/10.4028/www.scientific.net/AMM.633-634.562
• Online since: September 2014
• Authors: Yong Hui Wu*, Deng Guang Yu, Qian Su, Cheng Lei Cai, Ji An Zhang, Jian Tao Zhang
• Keywords: Biphasic Release, Composite, Electrospraying, Microparticle, Sustained-Release

References

[1] O.C. Farokhzad and R. Langer. ACS Nano Vol. 3 (2009), p.16.

[2] D.G. Yu, W. Qian, X. Wang, Y. Li, W. Lu and Y Zhang. Adv. Mater. Res. Vol. 675 (2013) p.326.

[3] O.V. Salata. Curr. Nanosci. Vol. 1 (2005), p.25.

[4] I.G. Loscertales, A. Barrero, I. Guerrero, R. Cortijo, M. Marquez and A.M. Canan-Calvo. Science Vol. 295 (2002), p.1695.

DOI: 10.1126/science.1067595

[5] W. Li, D.G. Yu, K. Chen, G. Wang and G.R. Williams. Mater. Lett. Vol. 93(2013), p.125.

[6] M. Eltayeb, E. Stride and M. Edirisinghe. Nanotechnology Vol. 24 (2013), p.465604.

[7] D.G. Yu, G.R. Williams, X. Wang, X.K. Liu, H.L. Li and S.W.A. Bligh. RSC Adv. Vol. 3 (2013), p.4652.

[8] D.G. Yu, X. Wang, X.Y. Li, W. Chian, Y. Li and Y.Z. Liao. Acta Biomater. Vol. 9(2013), p.5665.

[9] D.G. Yu, F. Liu, L. Cui, Z.P. Liu, X. Wang and S.W.A. Bligh. RSC Adv. Vol. 3 (2013), p.17775.

[10] J.M. Yang, L. Zha, D.G. Yu, and J. Liu. Colloid Surfaces B Biointerf. Vol. 102 (2012), p.737.

[11] S. Limmatvapirat, C. Limmatvapirat, S. Puttipipatkhachorn, J. Nuntanid, and M. Luangtana-anan. Eur. J. Pharm. Biopharm. Vol. 67 (2007) p.690.

DOI: 10.1016/j.ejpb.2007.04.008